BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1753269)

  • 1. Mass screening for rectal neoplasm in Jiashan County, China.
    Zheng GM; Choi BC; Yu XR; Zou RB; Shao YW; Ma XY
    J Clin Epidemiol; 1991; 44(12):1379-85. PubMed ID: 1753269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster randomization trial of sequence mass screening for colorectal cancer.
    Zheng S; Chen K; Liu X; Ma X; Yu H; Chen K; Yao K; Zhou L; Wang L; Qiu P; Deng Y; Zhang S
    Dis Colon Rectum; 2003 Jan; 46(1):51-8. PubMed ID: 12544522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
    Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a colorectal cancer screening protocol in an economically and medically underserved population.
    Cai SR; Zhang SZ; Zhu HH; Huang YQ; Li QR; Ma XY; Yao KY; Zheng S
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1572-9. PubMed ID: 21952582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age-specific detection rates of colorectal neoplasms by colonoscopic screening in high-incidence rural area].
    Li QL; Ma XY; Yu LL; Xue F; Ma WL; Yao KY
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):154-7. PubMed ID: 23714674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
    Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
    J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia.
    Rozen P; Ron E; Fireman Z; Hallak A; Grossman A; Baratz M; Rattan J; Gilat T
    Cancer; 1987 Nov; 60(10):2553-8. PubMed ID: 3664435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of effectiveness of mass screening for colorectal cancer.
    Fujita M; Sugiyama R; Kumanishi Y; Ota J; Horino T; Nakano Y; Taguchi T
    World J Surg; 1990; 14(5):648-52; discussion 652-3. PubMed ID: 2238667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
    McGarrity TJ; Long PA; Peiffer LP
    Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
    Hofbauer F; Mach K; Egermann G
    Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
    Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
    Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
    Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
    [No Abstract]   [Full Text] [Related]  

  • 18. [The screening model for early diagnosis of colorectal cancer in general population].
    Zheng S
    Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):381-4, 28. PubMed ID: 1659480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
    Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.